PP Episode 9: Is Obesity Over? | Big Pharma's Fat Profits Come At A Cost

The obesity market is big business. The makers of so-called "miracle" obesity and diabetes treatments like Mounjaro and Ozempic stand to make hundreds of BILLIONS of dollars over the next decade if they're further approved by the FDA and widely prescribed. Investors are already picking the winners as Eli Lilly has quickly become the most valuable healthcare company at a whopping $500 billion dollars. Will congress get on board and approve these treatments under Medicare? Will private insurance cover them? How will these drugs affect other industries like fast food? And how safe are they? Plus, we delve into the dirty details of Dave Portnoy and Barstool getting offloaded by Penn Gaming, which pisses Ben off. Get bonus content on Patreon Hosted on Acast. See acast.com/privacy for more information. Learn more about your ad choices. Visit podcastchoices.com/adchoices